Through substantial leadership turnover and workforce cuts, the FDA has continued to support the advanced therapy sector, ...
Fred Hutch bioengineer Dr. Matthias Stephan is working to develop a special foam that could help make gene therapy for blood ...
Non-exclusive license providing Solid’s proprietary, next-generation capsid, AAV-SLB101, to Andelyn Biosciences, a ...
The current negative list restricts foreign investment in the development and application of human stem cells and gene ...
Promising results from a small clinical trial highlight a growing interest in designing gene-editing treatments for common ...
The Sickle Cell Disease Treatment Market offers significant opportunities with advancements in gene editing, stem cell therapies, and precision medicine driving innovation. Increased awareness and ...
A physician-scientist who last year joined the University of Colorado Cancer Center team will soon steer the first human ...
The regenerative medicine market offers significant opportunities in personalized stem cell therapies, driven by rising ...
This experienced biopharmaceutical executive joined the C3i Center's management team on November 10, 2025, to strengthen commercialization and partnership strategies ...
Treatment Market is projected to grow at a healthy rate of around 13% by 2026. This growth is primarily driven by the ...
The research will support the implementation of precision medicine efforts for the population. Read more at straitstimes.com. Read more at straitstimes.com.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback